Headache Clinical Trial
Official title:
The Use of Ibuprofen and Acetaminophen for Acute Headache in the Post Concussive Youth: A Pilot Study.
Concussions and headache are a significant problem for children and athletes. While headache
generally resolves within 7-10 days; a significant proportion of children, 72-93% experience
prolonged headache as a symptom of Post Concussion Syndrome (PCS). The prevailing clinical
view is that mild head injuries resolve with little chance of complications. However, the
reality is quite different. Concussion in children presents with a range of severity and
results in both short and long-term physical, cognitive, emotional and behavioural sequelae
known as PCS with varying times to resolution. To date there are no specific treatments for
headache pain related to concussion. Physical and cognitive rest is the mainstay of initial
concussion management.
The number of children presenting to ED's with a history of concussion and headache is
increasing. Presently there are no evidence based guidelines available to guide the medical
team to effectively and consistently manage their headache. Our present standard of care is
based on the CANCHILD concussion guidelines outlining the child's return to school and
activity. Yet, our present standard of treatment is compromised and somewhat
counterproductive if we are not treating the child's headache pain.
Our pilot study ' An Open Label Randomized Control Pilot Study Examining Treatment of
Headache In The Post-Concussive Youth' showed that routine administration of oral analgesia
improves the child's headache symptoms and helps with school re-entry one week post injury,
compared to a standard care group defined as non routine administration of pain medications.
Objective Post Injury concussion and headache are problematic for children after mild
traumatic brain injuries. There are no evidence based guidelines for the management of acute
post concussive headache. The objectives of this study were to assess the efficacy of
routine administration of analgesia on concussion headache and classify headaches using the
IHS criteria.
Method A 4 arm open label pilot RCT study was conducted. The treatment arms were: (i)
acetaminophen,(ii) ibuprofen, (iii) acetaminophen and ibuprofen and (iv) a standard control
group. Eight to eighteen year olds presenting to emergency with headache 24-48 hours after
their first concussion were recruited consecutively and sequentially randomized. Demographic
data was collected, headache survey administered and standard concussion education given.
Headaches were diarized over one week capturing the (i) number of headaches, (ii) headache
days,(iii) headache intensity and (iv) return to school.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03472872 -
A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
|
Phase 4 | |
Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
Withdrawn |
NCT02866084 -
Neuromodulation Treatment of Vestibular Migraines
|
N/A | |
Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Not yet recruiting |
NCT04352218 -
Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache
|
Phase 2 | |
Completed |
NCT02734992 -
Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers
|
N/A | |
Completed |
NCT01327118 -
Prostaglandin F2alpha in a Human Headache Model
|
N/A | |
Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
Not yet recruiting |
NCT00969995 -
Identification of Inflammatory Markers in Migraine Patients
|
N/A | |
Not yet recruiting |
NCT00752921 -
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache
|
Phase 4 | |
Completed |
NCT00212810 -
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
|
Phase 4 | |
Terminated |
NCT00291395 -
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00263094 -
An End to the Yom Kippur (and Ramadan) Headache
|
N/A | |
Completed |
NCT00135122 -
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
|
Phase 3 | |
Completed |
NCT02475005 -
An Intervention to Improve Adolescent Headache Self-management
|
N/A | |
Completed |
NCT03163901 -
The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury
|
N/A | |
Completed |
NCT01664585 -
Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life
|
N/A | |
Completed |
NCT04632420 -
Evaluation of Headache and Childbirth in a Chronic Pain Population
|
||
Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|